An analysis of CTCL patients demonstrated that increased numbers of FOXP3+ Tregs are associated with improved survival in both MF and CTCL unspecified [42]. The gene discussed is FOXP3; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.